Of the $12.49 billion total, $12.15 billion was in long-term investments while $339.7 million was in operating cash. The long-term investment figure represented a 3.3 percent improvement on the previous month.
The clinic, whose president and CEO, Tom Mihaljevic, MD, said in January the system would post $200 million in operating losses for 2022, had liabilities totaling $500.8 million as of Jan. 31.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
